Search - tctmd.com

Displaying 101 - 120 of 122

Sort: Relevancy | Date

Presentation TCT 2014

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Ramon Quesada

September 13, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

Anatomical Effect on Left Atrial After Transcatheter Left Atrial Appendage Devices: Watchman and Amplatzer Cardiac Plug in a Canine Model

Presenter: Dongming Hou

October 29, 2013

Presentation TCT 2013

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Presenter: Gerald Werner

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Presenter: Saibal Kar

October 28, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

Presentation TCT 2013

Watchman

Presenter: Saibal Kar

October 27, 2013

Presentation TCT 2013

Deep Dive of the Watchman Data: PROTECT AF, CAP, and PREVAIL Efficacy

Presenter: David Holmes Jr

October 27, 2013

Presentation TCT 2013

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

Presenter: Saibal Kar

October 27, 2013

News Conference News TCT 2012

Watchman LAA Effective in Patients Contraindicated for Warfarin

October 26, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

Presentation TCT 2012

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Presenter: David Muller

October 24, 2012

Presentation TCT 2012

WATCHMAN Tips and Tricks

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Case Presentation: A Complicated WATCHMAN Case

Presenter: Horst Sievert

October 23, 2012

Video

» Interview

AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

November 5, 2021

Video

» Interview

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

November 5, 2021

Advertisement

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Anatomical Effect on Left Atrial After Transcatheter Left Atrial Appendage Devices: Watchman and Amplatzer Cardiac Plug in a Canine Model

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Experts Discuss Efficacy, Safety of Watchman Device

Watchman

Deep Dive of the Watchman Data: PROTECT AF, CAP, and PREVAIL Efficacy

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

Watchman LAA Effective in Patients Contraindicated for Warfarin

Novel Devices Provide Options for LAA Therapy

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

WATCHMAN Tips and Tricks

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Case Presentation: A Complicated WATCHMAN Case

AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content